Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from two pivotal phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist
Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid
Though commonplace for many people, birth control is a complex process that requires careful follow-through
However, peak effectiveness does not always correlate with the highest dosesome individuals experience substantial weight loss at 1.0 or 1.7 mg weekly with fewer side effects
Anti-obesity medications, notably semaglutide and tirzepatide, have significantly influenced the trajectory of prescription drug expenditures